Randy Milby - May 25, 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (HILS)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Stock symbol
HILS
Transactions as of
May 25, 2022
Transactions value $
$786
Form type
4
Date filed
5/25/2022, 05:28 PM
Previous filing
May 23, 2022
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HILS Common Stock Purchase $154 +200 +0.01% $0.77 2.94M May 25, 2022 Direct
transaction HILS Common Stock Purchase $632 +800 +0.03% $0.79 2.94M May 25, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.